Core Laboratories NV
NYSE:CLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (9.2), the stock would be worth $0.4 (97% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 313.5 | $13.76 |
0%
|
| Industry Average | 9.2 | $0.4 |
-97%
|
| Country Average | 16.4 | $0.72 |
-95%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| NL |
|
Core Laboratories NV
NYSE:CLB
|
675.3m USD | 313.5 | 21.4 | |
| US |
|
Schlumberger NV
NYSE:SLB
|
85.1B USD | 31.1 | 25.4 | |
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
69.1B USD | 33.9 | 22.1 | |
| US |
|
Halliburton Co
NYSE:HAL
|
35.3B USD | 20.7 | 22.6 | |
| LU |
|
Tenaris SA
MIL:TEN
|
27.6B EUR | 18.3 | 16.9 | |
| UK |
|
TechnipFMC PLC
NYSE:FTI
|
30.3B USD | 33.3 | 31.2 | |
| CN |
|
Yantai Jereh Oilfield Services Group Co Ltd
SZSE:002353
|
140.3B CNY | 74.5 | 50 | |
| UK |
|
Subsea 7 SA
OSE:SUBC
|
98.7B NOK | 14.3 | 25.4 | |
| IT |
|
Saipem SpA
MIL:SPM
|
8.9B EUR | 42.6 | 18.8 | |
| FR |
|
Technip Energies NV
PAR:TE
|
7.1B EUR | 14.4 | 19.4 | |
| US |
|
Weatherford International PLC
NASDAQ:WFRD
|
7.9B USD | 38.8 | 17.1 |
Market Distribution
| Min | 1.8 |
| 30th Percentile | 11.7 |
| Median | 16.4 |
| 70th Percentile | 33.6 |
| Max | 11 481.8 |
Other Multiples
Core Laboratories NV
Glance View
Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. The company is headquartered in Amstelveen, Noord-Holland and currently employs 3,700 full-time employees. The firm operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The company provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
